CAP Partners LLC Makes New Investment in DocuSign, Inc. (NASDAQ:DOCU)

CAP Partners LLC acquired a new position in DocuSign, Inc. (NASDAQ:DOCU) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 2,862 shares of the company’s stock, valued at approximately $257,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DOCU. Modus Advisors LLC purchased a new stake in shares of DocuSign during the fourth quarter valued at approximately $36,000. Itau Unibanco Holding S.A. purchased a new stake in shares of DocuSign during the 3rd quarter valued at $28,000. Brooklyn Investment Group purchased a new position in shares of DocuSign in the 3rd quarter worth about $33,000. Avior Wealth Management LLC grew its position in DocuSign by 36.5% during the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after buying an additional 145 shares during the period. Finally, Friedenthal Financial bought a new stake in DocuSign in the fourth quarter worth about $54,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.

DocuSign Price Performance

DOCU stock opened at $90.86 on Tuesday. The firm has a 50 day simple moving average of $92.58 and a two-hundred day simple moving average of $74.47. The stock has a market cap of $18.36 billion, a PE ratio of 18.73, a P/E/G ratio of 7.56 and a beta of 0.89. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Needham & Company LLC reiterated a “hold” rating on shares of DocuSign in a research note on Tuesday, February 4th. Morgan Stanley upped their price objective on shares of DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a report on Friday, December 6th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $90.00 target price (up previously from $57.00) on shares of DocuSign in a research note on Friday, December 6th. JPMorgan Chase & Co. raised their price objective on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Tuesday, December 3rd. Finally, Jefferies Financial Group increased their price objective on DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, DocuSign has a consensus rating of “Hold” and a consensus price target of $92.45.

Insider Buying and Selling

In other DocuSign news, CEO Allan C. Thygesen sold 7,763 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total value of $625,232.02. Following the completion of the sale, the chief executive officer now owns 100,062 shares of the company’s stock, valued at $8,058,993.48. This represents a 7.20 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Daniel D. Springer sold 581,588 shares of DocuSign stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total transaction of $56,437,299.52. Following the transaction, the director now directly owns 906,430 shares in the company, valued at $87,959,967.20. This trade represents a 39.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 685,773 shares of company stock worth $66,032,726. Corporate insiders own 1.66% of the company’s stock.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.